Literature DB >> 6524527

The inflammatory response of hyperthyroid and hypothyroid rats. Role of adrenocortical steroids.

Y Cury, J Garcia-Leme.   

Abstract

The capacity to respond to inflammatory stimuli was tested in hyperthyroid and hypothyroid rats when thyroid defects, induced by hormone administration or thyroparathyroidectomy, respectively, were fully established. Whereas hyperthyroid rats presented consistently depressed inflammatory responses, hypothyroid rats responded in a normal fashion. Decreased reactions to intracutaneously injected histamine and serotonin, inhibited swelling reaction to carrageenin, injected into one of the hind paws, and depressed primary and secondary reactions to adjuvant (heat-killed M. tuberculosis), only occurred in the hyperthyroid group. In addition, only in this group of animals enlargement of the adrenal glands, reduced content of adrenal ascorbic acid, and decreased number of circulating eosinophils, which characterize a circumstance of adrenal cortical hyperactivity, were observed. A spontaneous reversal of the acute inflammatory response of hyperthyroid animals to carrageenin occurred 3-4 days after interruption of hormone administration, and this was coincidental with the return to normal of the previously enlarged adrenal glands. Similarly, specific inhibition of adrenal cortical steroid biosynthesis in hyperthyroid rats with aminoglutethimide, restored the previously depressed response to carrageenin, without interference with the increased levels of seric thyroxin, thus suggesting that the inhibitory effects of thyroid hormones on inflammatory responses are likely to be indirect. It is concluded that an excess of circulating thyroid hormones, but not their deficiency, can impair the development of inflammatory reactions, and that this effect, at least partially, depends on an increased secretion of adrenal corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6524527     DOI: 10.1007/bf01972375

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  37 in total

1.  LYMPHATIC DRAINAGE AND ADJUVANT-INDUCED ARTHRITIS IN RATS.

Authors:  B B NEWBOULD
Journal:  Br J Exp Pathol       Date:  1964-08

2.  Does thyro-parathyroidectomy abolish the antiphlogistic actions of cortisone?

Authors:  P BOIS; H SELYE
Journal:  Experientia       Date:  1956-03-15

3.  Fate of adrenal ascorbic acid: relationship to corticosteroid secretion.

Authors:  M A SLUSHER; S ROBERTS
Journal:  Endocrinology       Date:  1957-07       Impact factor: 4.736

4.  5-Hydroxytryptamine and the anaphylactoid reaction in the rat.

Authors:  J R PARRATT; G B WEST
Journal:  J Physiol       Date:  1957-11-14       Impact factor: 5.182

5.  The assay of adrenocorticotrophic hormone by the adrenal ascorbic acid-depletion method.

Authors:  M A SAYERS; G SAYERS; L A WOODBURY
Journal:  Endocrinology       Date:  1948-05       Impact factor: 4.736

6.  Evaluation of a simplified technique for the specific measurement of serum thyroxine concentration.

Authors:  L E Braverman; A G Vagenakis; A E Foster; S H Ingbar
Journal:  J Clin Endocrinol Metab       Date:  1971-04       Impact factor: 5.958

7.  Immunodepression in thyroid-deprived animals.

Authors:  N Fabris
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

8.  Endogenous corticosteroids and insulin in acute inflammation.

Authors:  F R Moraes; J Garcia Leme
Journal:  Microvasc Res       Date:  1982-05       Impact factor: 3.514

Review 9.  Adrenal glucocorticoids after twenty years. A review of their clinically relevant consequences.

Authors:  D S David; M H Grieco; P Cushman
Journal:  J Chronic Dis       Date:  1970-03

10.  A comparative morphometric analysis of the effects of thyroxine and ACTH on the zona fasciculata of rat adrenal cortex.

Authors:  N A Moore; R K Boler
Journal:  Am J Anat       Date:  1976-04
View more
  1 in total

1.  Hormonal control of inflammatory responses.

Authors:  J Garcia-Leme; S P Farsky
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.